{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:27:25Z","timestamp":1780356445790,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The performance of drug-coated balloons (DCBs) in femoropopliteal interventions has been proven through randomized trials in short lesions and lesions with relatively low proportion of occlusions. There is limited evidence of DCBs in long or occlusive lesions. This study is to investigate the efficacy of the paclitaxel-coated balloon for treatment of long and occlusive femoropopliteal arterial lesions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A single-arm trial including 44 femoropopliteal lesions (chronic total occlusion (CTO) plus &gt;\u200910\u2009cm) treated with DCBs was performed to collect data of average 1-year follow-up. Endpoints contain primary patency, target lesion revascularization (TLR), amelioration of the Rutherford classification, change of ankle brachial index (ABI) and major adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Technical success is 97.7% while device success is 100%. Mean lesion length was 186\u2009\u00b1\u200986.3\u2009cm. Stent implantation was performed in 13.6%. Cumulative probability of primary patency was 78.8%\u2009\u00b1\u20096.8% at 1\u2009year while that of freedom from TLR was 91.4%\u2009\u00b1\u20094.9%. Rutherford classification improved from average 3.3\u2009\u00b1\u20091.0 to 2.1\u2009\u00b1\u20091.4 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) at follow-up with a 72.7% amelioration rate. Ankle-branchial index changed from 0.33\u2009\u00b1\u20090.40 to 0.67\u2009\u00b1\u20090.37 (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). No major adverse event was observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results suggest that it is safe and effective to treat long and totally occlusive femoropopliteal artery disease with DCBs. Further studies are demanded to confirm these results.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-020-01356-w","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T13:22:56Z","timestamp":1583500976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["One-year results of drug-coated balloons for long and occlusive Femoropopliteal artery disease: a single-arm trial"],"prefix":"10.1186","volume":"20","author":[{"given":"Zhichao","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-959X","authenticated-orcid":false,"given":"Bao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"issue":"7","key":"1356_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jcin.2017.01.028","volume":"10","author":"A Micari","year":"2017","unstructured":"Micari A, Nerla R, Vadal\u00e0 G, Castriota F, Grattoni C, Liso A, et al. 2-year results of paclitaxel-coated balloons for long femoropopliteal artery disease: evidence from the SFA-long study. J Am Coll Cardiol Intv. 2017;10(7):728\u201334.","journal-title":"J Am Coll Cardiol Intv"},{"issue":"7","key":"1356_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jcin.2015.12.267","volume":"9","author":"A Schmidt","year":"2016","unstructured":"Schmidt A, Piorkowski M, G\u00f6rner H, Steiner S, Bausback Y, Scheinert S, et al. Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry. J Am Coll Cardiol Intv. 2016;9(7):715\u201324.","journal-title":"J Am Coll Cardiol Intv"},{"issue":"2","key":"1356_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/1526602815626557","volume":"23","author":"K Katsanos","year":"2016","unstructured":"Katsanos K, Spiliopoulos S, Paraskevopoulos I, Diamantopoulos A, Karnabatidis D. Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability. J Endovasc Ther. 2016;23(2):356\u201370.","journal-title":"J Endovasc Ther"},{"issue":"5","key":"1356_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous Transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery DiseaseCLINICAL PERSPECTIVE: 12-month results from the IN. PACT SFA Randomized Trial. Circulation. 2015;131(5):495\u2013502.","journal-title":"Circulation"},{"issue":"2","key":"1356_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1406235","volume":"373","author":"K Rosenfield","year":"2015","unstructured":"Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373(2):145\u201353.","journal-title":"N Engl J Med"},{"issue":"3","key":"1356_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jcin.2011.11.010","volume":"5","author":"A Micari","year":"2012","unstructured":"Micari A, Cioppa A, Vadal\u00e0 G, Castriota F, Liso A, Marchese A, et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. J Am Coll Cardiol Intv. 2012;5(3):331\u20138.","journal-title":"J Am Coll Cardiol Intv"},{"issue":"3","key":"1356_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1583\/13-4630MR.1","volume":"21","author":"T Zeller","year":"2014","unstructured":"Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, et al. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther. 2014;21(3):359\u201368.","journal-title":"J Endovasc Ther"},{"issue":"9","key":"1356_CR8","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jcin.2016.02.014","volume":"9","author":"A Micari","year":"2016","unstructured":"Micari A, Vadal\u00e0 G, Castriota F, Liso A, Grattoni C, Russo P, et al. 1-year results of paclitaxel-coated balloons for long femoropopliteal artery disease: evidence from the SFA-long study. J Am Coll Cardiol Intv. 2016;9(9):950\u20136.","journal-title":"J Am Coll Cardiol Intv"},{"issue":"5","key":"1356_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jcin.2018.12.004","volume":"12","author":"G Tepe","year":"2019","unstructured":"Tepe G, et al. Drug-coated balloon treatment for femoropopliteal artery disease: the chronic total occlusion cohort in the IN. PACT global study. J Am Coll Cardiol Intv. 2019;12(5):484\u201393.","journal-title":"J Am Coll Cardiol Intv"},{"issue":"1","key":"1356_CR10","doi-asserted-by":"publisher","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","volume":"11","author":"PA Schneider","year":"2018","unstructured":"Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, et al. Treatment effect of drug-coated balloons is durable to 3 years in the Femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv. 2018;11(1):e005891.","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"1356_CR11","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1002\/ccd.25387","volume":"83","author":"KJ Rocha-Singh","year":"2014","unstructured":"Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83(6):E212\u201320.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"1356_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1177\/1526602816656612","volume":"23","author":"S Okuno","year":"2016","unstructured":"Okuno S, et al. Impact of calcification on clinical outcomes after endovascular therapy for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. J Endovasc Ther. 2016;23(5):731\u20137.","journal-title":"J Endovasc Ther"},{"issue":"1","key":"1356_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","volume":"8","author":"G Tepe","year":"2015","unstructured":"Tepe G, Schnorr B, Albrecht T, Brechtel K, Claussen CD, Scheller B, et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. J Am Coll Cardiol Intv. 2015;8(1):102\u20138.","journal-title":"J Am Coll Cardiol Intv"},{"key":"1356_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/VHRM.S81122","volume":"12","author":"M Herten","year":"2016","unstructured":"Herten M, Torsello GB, Sch\u00f6nefeld E, Stahlhoff S. Critical appraisal of paclitaxel balloon angioplasty for femoral\u2013popliteal arterial disease. Vasc Health Risk Manag. 2016;12:341\u201356.","journal-title":"Vasc Health Risk Manag"},{"key":"1356_CR15","first-page":"2378","volume-title":"Drug-Coated Balloons for In-Stent Restenosis: A Fierce Fight for a \u201cMe-Too\u201d Space","author":"JF Granada","year":"2018","unstructured":"Granada JF. Drug-Coated Balloons for In-Stent Restenosis: A Fierce Fight for a \u201cMe-Too\u201d Space; 2018. p. 2378\u201380."},{"issue":"2","key":"1356_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","volume":"96","author":"DI Axel","year":"1997","unstructured":"Axel DI, Kunert W, G\u00f6ggelmann C, Oberhoff M, Herdeg C, K\u00fcttner A, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96(2):636.","journal-title":"Circulation."},{"key":"1356_CR17","doi-asserted-by":"publisher","first-page":"K32","DOI":"10.4244\/EIJV7SKA6","volume":"7","author":"YP Clever","year":"2011","unstructured":"Clever YP, Cremers B, Krauss B, B\u00f6hm M, Speck U, Laufs U, et al. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells. EuroIntervention. 2011;7:K32\u201342.","journal-title":"EuroIntervention"},{"issue":"21","key":"1356_CR18","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","volume":"66","author":"JR Laird","year":"2015","unstructured":"Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, et al. Durability of treatment effect using a drug-coated balloon for Femoropopliteal lesions. J Am Coll Cardiol. 2015;66(21):2329\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1356_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrcardio.2013.165","volume":"11","author":"RA Byrne","year":"2014","unstructured":"Byrne RA, Joner M, Alfonso F, Kastrati A. Drug-coated balloon therapy in coronary and peripheral artery disease. Nat Rev Cardiol. 2014;11(1):13\u201323.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"1356_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ccd.25900","volume":"86","author":"H Schroeder","year":"2015","unstructured":"Schroeder H, Meyer DR, Lux B, Ruecker F, Martorana M, Duda S, et al. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study. Catheter Cardiovasc Interv. 2015;86(2):278\u201386.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"1356_CR21","first-page":"278","volume":"21","author":"N Farraj","year":"2009","unstructured":"Farraj N, Srivastava A, Pershad A. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft. J Invasive Cardiol. 2009;21(6):278\u201381.","journal-title":"J Invasive Cardiol"},{"issue":"2","key":"1356_CR22","first-page":"58","volume":"28","author":"J Matsumi","year":"2016","unstructured":"Matsumi J, et al. Long-term outcomes of self-expandable Nitinol stent implantation with intraluminal angioplasty to treat chronic Total occlusion in the superficial femoral artery (TransAtlantic inter-society consensus type D lesions). J Invasive Cardiol. 2016;28(2):58\u201364.","journal-title":"J Invasive Cardiol"},{"issue":"18","key":"1356_CR23","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","volume":"9","author":"X Jia","year":"2016","unstructured":"Jia X, Zhang J, Zhuang B, Fu W, Wu D, Wang F, et al. Acotec drug-coated balloon catheter. J Am Coll Cardiol Intv. 2016;9(18):1941\u20139.","journal-title":"J Am Coll Cardiol Intv"},{"issue":"6","key":"1356_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","volume":"5","author":"M Werk","year":"2012","unstructured":"Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, et al. Paclitaxel-coated balloons reduce restenosis after Femoro-popliteal angioplasty evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5(6):831\u201340.","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"1356_CR25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s00270-014-0904-3","volume":"37","author":"F Fanelli","year":"2014","unstructured":"Fanelli F, Cannavale A. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Interv Radiol. 2014;37(4):898\u2013907.","journal-title":"Cardiovasc Interv Radiol"},{"issue":"5","key":"1356_CR26","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jvs.2014.03.291","volume":"62","author":"A Diamantopoulos","year":"2014","unstructured":"Diamantopoulos A, Gupta Y, Zayed H, Katsanos K. Paclitaxel-coated balloons and aneurysm formation in peripheral vessels. J Vasc Surg. 2014;62(5):1320\u20132.","journal-title":"J Vasc Surg"},{"issue":"7","key":"1356_CR27","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/ccd.23460","volume":"80","author":"D Vassilev","year":"2012","unstructured":"Vassilev D, Hazan M, Dean L. Aneurysm formation after drug-eluting balloon treatment of drug-eluting in-stent restenosis: first case report. Catheter Cardiovasc Interv. 2012;80(7):1223\u20136.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01356-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-020-01356-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01356-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:22:38Z","timestamp":1612484558000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01356-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01356-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"assertion":[{"value":"16 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board of Peking Union Medical College Hospital approved this study. Written informed consents were signed by all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}